Related Experiment Video
Updated: Jun 8, 2026
06:07
Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
Published on: June 23, 2023
α-Synuclein impairs macroautophagy: implications for Parkinson's disease
Ashley R Winslow1, Chien-Wen Chen, Silvia Corrochano
1Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, England, UK.
The Journal of Cell Biology
|September 22, 2010
Summary
Overexpression of alpha-synuclein impairs macroautophagy by inhibiting Rab1a, a key protein in the autophagy pathway. Restoring Rab1a levels can rescue this defect, offering potential therapeutic insights for Parkinson's disease.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Parkinson's disease (PD) is pathologically defined by Lewy bodies, primarily composed of alpha-synuclein.
- Genetic studies show that alpha-synuclein gene multiplication leads to PD, indicating overexpression is toxic.
Purpose of the Study:
- To investigate the impact of alpha-synuclein overexpression on macroautophagy in mammalian cells and mice.
- To elucidate the mechanism by which alpha-synuclein affects autophagy.
Main Methods:
- Utilized mammalian cell cultures and transgenic mouse models.
- Assessed macroautophagy function and protein localization (Rab1a, Atg9).
- Investigated the role of Rab1a in mediating alpha-synuclein's effects on autophagy.
Main Results:
- Alpha-synuclein overexpression significantly impairs macroautophagy.
- This impairment is mediated by the inhibition of Rab1a.
- Rab1a overexpression rescues the autophagy defect, while Rab1a knockdown exacerbates it.
- Alpha-synuclein-induced autophagy inhibition leads to Atg9 mislocalization and reduced omegasome formation.
Conclusions:
- Alpha-synuclein overexpression disrupts macroautophagy through Rab1a inhibition.
- Rab1a is a critical regulator of omegasome formation and autophagosome precursor assembly.
- Targeting the Rab1a pathway may offer a therapeutic strategy for Parkinson's disease.
More Related Videos
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:27Autophagy
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...